Pfizer slumps after slashing full-year profit forecast on tumbling Covid sales

Australia News News

Pfizer slumps after slashing full-year profit forecast on tumbling Covid sales
Australia Latest News,Australia Headlines
  • 📰 startelegram
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 63%

Pfizer said slumping demand for its Comirnaty covid vaccine and its Paxlovid antiviral treatment will mean sharply lower revenues for the full year.

shares slumped lower in pre-market trading after the drugmaker slashed its full-year sales and profits forecasts, while unveiling steep job cuts, linked to slowing demand for its Covid vaccines and treatments.

In response, Pfizer said it would write-off around $4.6 billion in Paxlovid inventories, while taking a further $5.5 billion non-cash charge against its third quarter earnings. It also unveiled plans for a $3.5 billion cost-cutting program, spread over two years, that will include a significant number of job cuts.

"Pfizer’s non-COVID product portfolio remains strong, and we continue to expect these products to achieve year-over-year operational revenue growth in the range of 6% to 8% in 2023," said CEO Albert Bourla.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

startelegram /  🏆 248. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

1 Stock to Buy, 1 Stock to Sell This Week: Lululemon, Pfizer1 Stock to Buy, 1 Stock to Sell This Week: Lululemon, PfizerStocks Analysis by Investing.com (Jesse Cohen) covering: Pfizer Inc, Lululemon Athletica Inc. Read Investing.com (Jesse Cohen)'s latest article on Investing.com
Read more »

BioNTech will likely take 900 million eur write-off on Pfizer-partnered vaccinesBioNTech will likely take 900 million eur write-off on Pfizer-partnered vaccinesBioNTech will likely take 900 million eur write-off on Pfizer-partnered vaccines
Read more »

Stock movers: Pfizer, Lululemon, BioNTech, Moderna, Novavax, Manchester UnitedStock movers: Pfizer, Lululemon, BioNTech, Moderna, Novavax, Manchester UnitedLululemon stock climbs ahead of S&P 500 inclusion
Read more »

Stock Market Today: Dow Futures Edge Up; Investors Eye Lululemon, PfizerStock Market Today: Dow Futures Edge Up; Investors Eye Lululemon, PfizerCharles Schwab is set to report earnings this morning; Middle East is in focus
Read more »

BioNTech’s stock sinks after disclosing expected charge of up to nearly $1 billion resulting from Pfizer’s write offs of COVID productsBioNTech’s stock sinks after disclosing expected charge of up to nearly $1 billion resulting from Pfizer’s write offs of COVID productsTomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter TomiKilgore.
Read more »

House lawmakers threaten to subpoena ex-NY Gov. Cuomo for COVID nursing home documentsHouse lawmakers threaten to subpoena ex-NY Gov. Cuomo for COVID nursing home documentsHouse lawmakers threaten to subpoena ex-NY Gov. Cuomo for COVID nursing home documents
Read more »



Render Time: 2025-02-27 18:14:46